LataMed AI Corp. (OTC: LMED) announced that development of its mobile healthcare application has entered its final stage, with the company completing testing, optimization, and deployment preparation. Management expects the app to be submitted for distribution and, subject to platform review, available through the Apple App Store and Google Play in the coming weeks. This transition from development to public availability is a significant milestone for the company, as it aims to provide a primary mobile access point to its digital healthcare ecosystem.
The application is designed to offer users a convenient interface for accessing supported healthcare services, digital tools, and additional functionality as the platform expands. The development team is focused on final technical testing, interface optimization, and platform compatibility. Once live, the app is expected to serve as a scalable mobile foundation for introducing patient-facing tools, healthcare-provider interaction, digital communications, and healthcare-service coordination.
Mobile accessibility is particularly crucial in Latin America, where smartphones are a primary means of accessing digital services for many individuals. By making the platform available on both major app marketplaces, LataMed AI intends to provide a more direct and accessible way for users to engage with its healthcare ecosystem. This move aligns with the company's long-term strategy of connecting patients, healthcare professionals, pharmacies, insurers, and wellness organizations in an integrated digital environment.
The company continues to develop its AI-supported technologies, including CardioAI, PulmoAI, and NeuroAI, as part of its broader healthcare technology strategy. The mobile infrastructure is intended to provide an additional pathway for users and professionals to interact with these components, subject to regulatory approvals and commercial implementation.
Dr. Kevin Rodan Levy, CEO of LataMed AI, emphasized the importance of this milestone: "Our mobile application is now moving from development toward deployment, and we believe we are approaching an important milestone for LataMed AI. Mobile availability is important because it provides a direct connection between users and the digital healthcare ecosystem we are building."
The anticipated release represents a step toward moving LataMed AI's technology from development into accessible, user-facing digital health infrastructure. Following the initial release, the company plans to evaluate additional functionality and integrations for future versions. LataMed AI will provide updates as it completes submission and platform-review milestones.
For more information, visit LataMed AI's website or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
